Colorado’s Ketamine Insurance Coverage Rules Are Changing in 2026
If you’ve been researching depression treatment in Colorado and gotten confused about what insurance actually pays for, you’re not alone. A new state law took effect this year requiring insurers to treat mental health coverage the same way they treat physical health coverage, and it’s landing right as more Coloradans are asking about ketamine and Spravato for treatment-resistant depression. The catch is that ketamine insurance coverage in Colorado still depends heavily on which form of treatment you’re getting.
Quick Answer: Ketamine Insurance Coverage in Colorado
Spravato, the FDA-approved nasal spray version of ketamine, is covered by most major Colorado insurance plans, including Colorado Medicaid, when patients meet treatment-resistant depression criteria. IV ketamine infusions are a different story: because they’re used off-label for depression, most insurers still classify them as not medically necessary and won’t pay for the drug itself, even though the therapy and monitoring around it may be billable.
Colorado’s New Parity Law and What It Changed
House Bill 25-1002 went into effect January 1, 2026, and it’s a bigger deal than most patients realize. The law requires every health benefit plan in the state to use nationally recognized, not-for-profit clinical criteria (rather than each insurer’s internal rulebook) when deciding whether behavioral health treatment is medically necessary, according to the full bill text on the Colorado General Assembly’s site. In practice, that means insurers can no longer quietly apply stricter standards to a mental health claim than they’d apply to a comparable physical health claim.
The Colorado Division of Insurance has been fielding a wave of consumer questions since the law took effect, and its guidance on mental health benefits is worth reading if you’re trying to figure out what your specific plan covers. Local coverage from 9News has also tracked how the rollout is playing out for Colorado patients navigating claims under the new standard.
What the Law Means for Spravato Ketamine Insurance Coverage
Spravato earned FDA approval for treatment-resistant depression back in 2019, and a supplemental approval has since expanded its use as a standalone monotherapy for adults who haven’t responded to standard antidepressants, per reporting on the FDA’s expanded approval. That clear, FDA-backed indication is exactly the kind of documentation insurers look for, which is a big part of why Spravato gets approved more consistently than other forms of ketamine.
Spravato: Covered by Most Major Plans
Most major carriers in Colorado, plus Colorado Medicaid, now cover Spravato for patients who’ve tried at least two antidepressants without adequate relief. You can review the Spravato treatment options available through Rose NeuroSpa to see how the protocol works and what a course of treatment looks like.
IV Ketamine: Still Mostly Out-of-Pocket
IV ketamine is a different animal from an insurance standpoint. Because it’s FDA-approved only as an anesthetic, using it for depression, anxiety, or PTSD counts as off-label, and most insurers still deny coverage for the infusion itself. Some patients find that the psychotherapy sessions built around IV ketamine integration are covered separately, even when the infusion isn’t. If you’re weighing the two paths, our page on IV ketamine infusion therapy breaks down how it differs from Spravato in practice.
What Most Coverage Misses About Ketamine Insurance in Denver
Most articles stop at “Spravato is covered, IV ketamine isn’t.” What they skip is that the new utilization review standards under HB25-1002 also apply to the surrounding care, things like psychiatric evaluation, medication management, and integration therapy, that patients often assume are lumped in with the drug cost. Those services now have to be judged against the same clinical necessity standard as physical health care, which can work in a patient’s favor even when the ketamine itself is cash-pay.
That’s also where a full diagnostic workup matters. A treatment-resistant depression diagnosis, documented properly, is often the difference between a denied claim and an approved one, regardless of which ketamine delivery method you end up choosing. Pairing that documentation with ongoing medication management services can also strengthen a claim, since it shows a coordinated, evidence-based treatment plan rather than a standalone procedure.
Before starting treatment, it’s worth reading through an overview of ketamine therapy so you know which questions to ask your insurer. Coverage details vary by plan year to year, so checking your specific benefits before you commit to a protocol saves both time and money.
Final Thoughts on Ketamine Insurance Coverage in Colorado
Colorado’s parity law is a real shift, but it doesn’t erase the gap between Spravato and IV ketamine when it comes to what your insurance will actually pay. Spravato has the FDA indication and the coverage history to back it up. IV ketamine, for now, is largely a self-pay decision, even as the therapy and support around it get pulled under the same medical necessity standard as everything else.
If you’re not sure which path fits your situation or your coverage, our team can walk through your options and your plan’s specifics together. Visit our insurance coverage page to see what to check on your policy, or schedule a consultation to talk through treatment-resistant depression care with someone who can help you sort out the real cost before you start.
